Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 2/20 | 0.51 |
| ▸ | SRC | P12931 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.44 |
| ▸ | CXCR1 | P25024 | 2/20 | 0.44 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.44 |
| ▸ | ALB | P02768 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | RARB | P10826 | 1/20 | 0.44 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.44 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28679705 | 0.87 | BLM (0.48) | BLMSRCCYP2C19SMN1; SMN2PTGS2 | |
| SCHEMBL21807707 | 0.86 | SLC6A4 (0.58) | BLMANPEPLAP3 | |
| SCHEMBL3123300 | 0.86 | SLC6A4 (0.58) | BLMANPEPLAP3 | |
| SCHEMBL1791289 | 0.85 | TSHR (0.52) | BLMCYP2C19SMN1; SMN2PTGS2PTGS1 | |
| SCHEMBL27680487 | 0.83 | LAP3 (0.53) | BLMSRCCYP2C19SMN1; SMN2PTGS2 | |
| SCHEMBL15601884 | 0.83 | LDHA (0.47) | BLMSRCCYP2C19SMN1; SMN2ANPEP | |
| SCHEMBL14733913 | 0.83 | BLM (0.46) | BLMSRCCYP2C19SMN1; SMN2CA1 | |
| SCHEMBL14369505 | 0.82 | BLM (0.45) | BLMSRCCYP2C19SMN1; SMN2CA1 | |
| SCHEMBL28494427 | 0.81 | PTGS2 (0.43) | BLMCYP2C19SMN1; SMN2PTGS2PTGS1 | |
| SCHEMBL15592509 | 0.80 | LDHA (0.45) | BLMSRCCYP2C19SMN1; SMN2PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11691976-B2 | Coelenterazine analogues | PROMEGA CORPORATION (US) | 2023-07-04 | — | — | US | disclosed |
| US-11136615-B2 | Compositions and methods for stabilizing benzothiazole luciferin analogs | PROMEGA CORPORATION (US) | 2021-10-05 | — | — | US | disclosed |
| CN-111480256-A | Electrolyte for lithium secondary battery and lithium secondary battery comprising the same | 株式会社LG化学 | 2020-07-31 | — | — | CN | disclosed |
| CN-111344323-A | Reactive flame retardant blends for flexible polyurethane foams | 爱思乐-艾博美国有限公司 | 2020-06-26 | — | — | CN | disclosed |
| US-20190040449-A1 | COMPOSITIONS AND METHODS FOR STABILIZING BENZOTHIAZOLE LUCIFERIN ANALOGS | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2019-02-07 | — | — | US | disclosed |
| CN-101506327-B | High-performance phosphate hydraulic oil | SOLUTIA INC | 2014-06-04 | — | — | CN | disclosed |
| CN-101506327-A | High-performance phosphate hydraulic oil | SOLUTIA INC (US) | 2009-08-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11691976-B2 | Coelenterazine analogues | GLB1, SI, TCF7L2 | BLM 1091/4885SRC 4413/4885CYP2C19 3234/4885 |
| US-20190040449-A1 | COMPOSITIONS AND METHODS FOR STABILIZING BENZOTHIAZOLE LUCIFERIN ANALOGS | TK1, TYMP, NUDT1 | BLM 286/4885SRC 3855/4885CYP2C19 2545/4885 |
| US-11136615-B2 | Compositions and methods for stabilizing benzothiazole luciferin analogs | TK1, TYMP, NUDT1 | BLM 286/4885SRC 3855/4885CYP2C19 2545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.